Sanctuary Advisors LLC Has $59,000 Position in ASP Isotopes Inc. (NASDAQ:ASPI)

Sanctuary Advisors LLC lessened its position in ASP Isotopes Inc. (NASDAQ:ASPI) by 44.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 13,040 shares of the company’s stock after selling 10,602 shares during the quarter. Sanctuary Advisors LLC’s holdings in ASP Isotopes were worth $59,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in shares of ASP Isotopes in the third quarter valued at about $6,249,000. Telemark Asset Management LLC acquired a new stake in shares of ASP Isotopes in the third quarter valued at about $4,726,000. Philadelphia Financial Management of San Francisco LLC increased its stake in shares of ASP Isotopes by 158.3% in the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares during the period. GSA Capital Partners LLP increased its stake in shares of ASP Isotopes by 96.0% in the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after buying an additional 377,721 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of ASP Isotopes by 42.7% in the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after buying an additional 334,836 shares during the period. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Trading Down 7.5 %

Shares of ASPI stock opened at $4.06 on Friday. The stock has a market cap of $289.84 million, a price-to-earnings ratio of -6.66 and a beta of 3.51. The stock has a 50-day moving average of $5.24 and a 200-day moving average of $4.70. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 1-year low of $1.86 and a 1-year high of $9.33.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.